Dasatinib in combination with fludarabine in patients with refractory chronic lymphocytic leukemia: a multicenter phase 2 study (Q33411506)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dasatinib in combination with fludarabine in patients with refractory chronic lymphocytic leukemia: a multicenter phase 2 study |
scientific article |
Statements
1 reference
Dasatinib in combination with fludarabine in patients with refractory chronic lymphocytic leukemia: a multicenter phase 2 study (English)
1 reference
Arnon P Kater
1 reference
Marjolein Spiering
1 reference
Roberto D Liu
1 reference
G Doreen Te Raa
1 reference
E Slinger
1 reference
Sanne H Tonino
1 reference
Marielle M Beckers
1 reference
Simon Daenen
1 reference
Jeanette K Doorduijn
1 reference
Nienke A G Lankheet
1 reference
Dieuwertje M Luijks
1 reference
Eric Eldering
1 reference
Marinus H J van Oers
1 reference
28 October 2013
1 reference
1 reference
38
1 reference
34-41
1 reference
Identifiers
1 reference
1 reference